Profile
| Metric | Value |
|---|---|
| Full Name | Baxter International Inc. |
| Ticker | NYSE: BAX |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Country | United States |
| IPO | |
| Indexes | |
| Website | baxter.com |
| Employees | 38,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $20.40 | |
| Price, 1D Change | -0.73% | |
| Market Cap | $10B | |
| TTM Dividend Yield | 2.55% | |
| PE Ratio | - | |
| Beta | 0.87 | |
| Revenue | $11B | |
| Revenue, 1Y Change | +2.66% | |
| EPS | -$1.27 | |
| EPS, 1Y Change | -184.95% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.01 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1841:1000 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$1.27 | |
| EPS Estimate | $2.36 | |
| EPS Est. Change | +285.71% | |
| Revenue | $10.64B | |
| Revenue Estimate | $11.08B | |
| Revenue Est. Change | +4.17% | |
| Current Price | $20.40 | |
| Price Target | - | $22.00 |
| Price Tgt. Change | - | +7.84% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.59 | -$0.45 | -117.24% | |
| $1.83 | -$1.27 | -169.59% | |
| $2.36 | N/A | +285.71% | |
| $2.29 | N/A | +280.21% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $14.74B | $10.36B | -29.72% | |
| $10.56B | $10.64B | +0.74% | |
| $11.08B | N/A | +4.17% | |
| $11.33B | N/A | +6.54% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -31.03% | |
| Price, 3Y | -57.89% | |
| Market Cap, 1Y | -30.61% | |
| Market Cap, 3Y | -57.09% | |
| Revenue, 1Y | +2.66% | |
| Revenue, 3Y | -16.80% | |
| EPS, 1Y | -184.95% | |
| EPS, 3Y | -150.35% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $20.40 | |
| SMA 200 | $25.33 | |
| SMA 200 vs Price | +24.16% | |
| SMA 50 | $18.97 | |
| SMA 50 vs Price | -7.00% | |
| Beta | 0.87 | |
| ATR | $0.51 | |
| 14-Day RSI | 64.91 | |
| 10-Day Volatility | 22.92% | |
| 1-Year Volatility | 43.32% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.01 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 5.10% | |
| Total Dividend | $1.04 | |
| Dividends Paid | $590.00M | |
| Payout Ratio | -180.98% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $10.64B | |
| EPS | -$1.27 | |
| Gross Profit | $3.85B | |
| Gross Margin | 36.24% | |
| Operating Profit | $687.00M | |
| Operating Margin | -57.31% | |
| Net Income | -$326.00M | |
| Net Margin | -3.07% | |
| EBITDA | $1.68B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 1.93 | |
| Current Ratio | 1.36 | |
| Quick Ratio | 1.05 | |
| - | ||
| F-Score | 5 | |
| Altman Z-Score | 1.76 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 0.95 | |
| PB Ratio | 1.45 | |
| EV/EBITDA | 10.67 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $6.96B | |
| Cash & Equivalents | $1.77B | |
| Total Assets | $25.78B | |
| Current Assets | $8.85B | |
| Total Liabilities | $18.76B | |
| Current Liabilities | $6.51B | |
| Total Debt | $13.45B | |
| Short Term Debt | $2.83B | |
| Accounts Payable | $968.00M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $10.97B | |
| Operating Expenses | $3.17B | |
| Cost Of Goods Sold | $6.78B | |
| SG&A | $0.00 | |
| D&A | $997.00M | |
| Interest Expense | $0.00 | |
| Income Tax | $37.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $1.02B | |
| CFI | -$626.00M | |
| CFF | -$1.08B | |
| Capex | $446.00M | |
| Free Cash Flow | $573.00M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Morgan Stanley | → | |
| UBS | → | |
| Goldman Sachs | → | |
| Citigroup | → | |
| Argus Research | → | |
| Evercore ISI Group | → | |
| UBS | → | |
| Stifel | → | |
| Barclays | → | |
| Wells Fargo | → |
Analyst sentiment
Institutional ownership
Screeners with BAX
Data Sources & References
- BAX Official Website www.baxter.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/10456/000162828025048897/0001628280-25-048897-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/10456/000162828025007201/0001628280-25-007201-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- BAX Profile on Yahoo Finance finance.yahoo.com/quote/BAX
- BAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bax
FAQ
What is the ticker symbol for Baxter International Inc.?
The ticker symbol for Baxter International Inc. is NYSE:BAX
Does Baxter International Inc. pay dividends?
Yes, Baxter International Inc. pays dividends. The last payment was $0.01, with an ex-dividend date on November 28, 2025
What sector is Baxter International Inc. in?
Baxter International Inc. is in the Healthcare sector
What industry is Baxter International Inc. in?
Baxter International Inc. is in the Medical Instruments & Supplies industry
What country is Baxter International Inc. based in?
Baxter International Inc. is headquartered in United States
When did Baxter International Inc. go public?
Baxter International Inc. initial public offering (IPO) was on October 27, 1981
Is Baxter International Inc. in the S&P 500?
Yes, Baxter International Inc. is included in the S&P 500 index
Is Baxter International Inc. in the NASDAQ 100?
No, Baxter International Inc. is not included in the NASDAQ 100 index
Is Baxter International Inc. in the Dow Jones?
No, Baxter International Inc. is not included in the Dow Jones index
When was Baxter International Inc. last earnings report?
Baxter International Inc.'s most recent earnings report was on October 30, 2025
When does Baxter International Inc. report earnings?
The next expected earnings date for Baxter International Inc. is February 19, 2026
